Welcome message

Welcome to the Summer School on Pharmaceutical Analysis!

In the last two decades, several innovative therapeutic approaches and drug modalities have come to light. However, advanced therapies still face high-level analytical challenges. As a new drug product develops, associated analytical methods also need to develop in parallel to ensure that the finished drug product meets the required quality standards. Failure to meet established quality standards can lead to the loss of the desired therapeutic effect and the appearance of toxic and adverse reactions, putting the final users at risk and wasting financial resources.

The focus of the 2024 and 2025 editions of the Summer School on Pharmaceutical Analysis will be on the specific aspects and analytical challenges associated with consolidated and emerging advanced therapies. In particular, document number one will cover New therapeutic approaches, new analytical challenges: peptide- and protein-based drugs.

Lectures will be delivered by recognized experts from the academic and industrial sectors. A list of confirmed speakers is available in the "Meet our Speakers" section.

The School's social activities are planned to promote networking and interaction between participants and lecturers. Due to this, the number of participants in attendance is limited to 80 to maximize these aspects.

We are committed to making SSPA2024 a tremendous opportunity for you to enhance your scientific competitiveness while also providing an enjoyable and friendly experience.

Join us in Rimini and take advantage of this opportunity to expand your knowledge of advanced pharmaceutical analysis, approaches, and challenges.

Manuela Bartolini
Chair of SSPA
Department of Pharmacy and Biotechnology, Alma Mater Studiorum University of Bologna

 
Main SSPA2024 Topics

Current status and perspective of biological/biotechnological drugs
Analytical challenges for biological drugs
Cleaning Verification
Analysis of “High‐risk” host cell proteins (HCPs)
GMP characterization of peptides, proteins, and antibodies
Glycosylation profiling
Stability studies
Multi-Attribute Methods (MAMs)
LBA method development and validation in biological matrices
Analysis of antibodies in biological matrices
Bioanalysis of Antibody-drug conjugates
Analytical method for the evaluation of immunogenicity
Case studies

The Summer School on Pharmaceutical Analysis (SSPA) is organized by the Divisione di Chimica Farmaceutica, Società Chimica Italiana (Division of Medicinal Chemistry, Italian Chemical Society) and sponsored by the European Federation for Medicinal Chemistry and Chemical Biology (EFMC).

Divisione di Chimica Farmaceutica, Società Chimica Italiana (Division of Medicinal Chemistry, Italian Chemical Society)
European Federation for Medicinal Chemistry and Chemical Biology

Location

Rimini (IT)

Date

18th-20th Sept 2024

Speakers

14 Drug Discovery Professionals

Tickets

80 Students

Location

The SSPA is housed in Aula 7 of the Alberti Complex (Aula Alberti 7), via Carlo Cattaneo 17, Rimini. Venue location is mapped here below. The school venue is conveniently located at a walking distance from the rail station and in Rimini city center.

By car

From North: A1 Motorway Milan – Bologna, then A14 Motorway Bologna – Rimini
From South: A14 Motorway Bari – Rimini
Exit: Rimini Sud (for Rimini centre)

By train

Rimini is well connected by train to all the main cities in central and northern Italy. High speed trains connect Rimini to Bologna (1 h), Milan (2.5 h), Florence (2 h), Ancona (1 h) and Rome (4 h) several times a day.
Main railway station: Piazzale Cesare Battisti
Tickets can be bought on-line through the Italian railway website.

By plane

The city airport (‘Federico Fellini’ International Airport) is located in Miramare di Rimini.
Federico Fellini International airport in Rimini Federico Fellini International www.riminiairport.com
Closest Internationl airport is the Bologna International airport www.bologna-airport.it<

Meet Our Speakers

Cristina Barbirato

Cristina Barbirato
 

Merck R.B.M., Ivrea, Italy; an affiliate of Merck KGaA, Darmstadt, Germany
Luigi Colombo

Luigi Colombo
 

Medical Technology Lab, Milano, Italy
 


Over 35 years in R&D in pharmaceutical companies, including Marion Merrell Dow, Hoechst Marion Roussell, Boehringer Ingelheim, Serono, and Merck. He co-founded Biosearch Italia, the first biotech company listed on the Italian Stock Exchange, which eventually went public on the Nasdaq and was acquired by Pfizer. Luigi currently works as an independent consultant. In addition to several collaborations in Pharma & Biotech, he is the CEO of Medical Technology Lab, an industrial holding company focused on seed investment in new technologies. Luigi graduated with honors in Chemistry and Pharmaceutical Technologies and served as an adjunct professor at the Università Statale di Milano (Italy).

Ettore Gilardoni

Ettore Gilardoni
 

Head of Mass Spectrometry
 
Philochem AG, Zurich, Switzerland
 


Ettore Gilardoni studied Medicinal Chemistry and Pharmaceutics and got the PhD in Pharmaceutical Sciences in 2021 at the University of Milan. He joined Philochem in April 2021 as Research Scientist and since July 2022 he leads the mass spectrometry team. The team main activities vary from biodistribution of small organic molecules in biospecimens; biopharmaceuticals characterization, and proteomics application for target identification; host cell proteins characterization, and mechanism of action evaluation. He is author of more than 25 scientific papers and 4 patents.

Silvia Lorenzi

Silvia Lorenzi
 

ADMET & Bioanalytical Sciences
 
Aptuit (Verona) S.r.l, an Evotec Company, Italy


Silvia Is a Senior Supervisor of Regulated Bioanalysis and Biomarker Immunoassay at Aptuit Verona. She has over 10 years in pharmaceutical development. She started as Associate Scientist in Merck R.B.M (Ivrea) in the Flow cytometry lab of the Clinical Biomarker unit, then she moved to Aptuit Verona where she worked for several years in the immunoassay lab conducting assays and ultrasensitive assays validation for Biomarkers quantification, PK, Immunophenotyping to support preclinical and clinical study. She is Study Director of validation studies and Responsible Scientist to support clinical phase studies. Silvia graduated with honors in Medical, Molecular and Cellular Biotechnology and holds a PhD in Immunology.

Francesca Morandini

Francesca Morandini
 

ADMET & Bioanalytical Sciences Department, Regulated Bioanalysis and Biomarkers Immunoassay Unit
 
Aptuit (Verona) S.r.l, an Evotec Company, Italy


Master's degree in Agro-Industrial Biotechnology at University of Verona in 2004, PhD in Applied Biotechnology at University of Verona in 2009, Post doc experience at the National Research Council of Milano (IBBA Institute) from 2009 to 2011, Post doc experience at University Laboratory for Medical Research, Unit of Internal Medicine at the University of Verona from 2011 to 2017, Senior scientist at Aptuit from 2017 to 2022, Principal scientist at Aptuit from 2022 up to now.

Elena Piccoli

Elena Piccoli
 

Biologics Bioassay
 
Frontage Europe S.r.l., Nerviano, Italy
 


I'm responsible of the Biologics Bioassay Unit in Frontage Europe since January 2024. Before, I was Head of Analytical Biology group in Accelera srl..I have more than 8-years' experience in development and validation of Ligand Binding assays (LBA) for the analysis of biological therapeutics as support to preclinical and clinical studies. I graduated in Biotechnology (MSc) in 2007. Between 2007 and 2015 I worked as Research Fellow at IRCCS Istituto Neurologico Carlo Besta in Milan, mainly involved in biochemical and biological research on neurodegenerative dementias.

Barbara Pioselli

Barbara Pioselli
 

Biomolecules Structural Characterization Unit, Analytics and Early Formulations Department
 
Chiesi Farmaceutici, Italy
 


Master's degree in Pharmaceutical Chemistry and Technology at University of Parma in 2001. PhD in Bio-chemical Sciences at University of Turin and University of Parma in 2004. Post doc experience at University of York (UK), Centre for Excellence in Mass Spectrometry from 2004 to 2007. Post doc experience at University of Parma from 2007 to 2009. Project Collaborator at Chiesi Farmaceutici R&D from 2009 to 2011. Senior scientist in Chiesi Farmaceutici R&D from 2011 and from 2013 Principal scientist and Biomolecules Structural Characterization Unit head in Global Research and Preclinical Development. From November 2023, student in First Level Master Degree in Scientific Communications at University of Parma.

Vincenzo Pisapia

Vincenzo Pisapia
 

NanoTemper Technologies, Munich, Germany
 


Vincenzo Pisapia is an Applications Specialist at NanoTemper Technologies, where he has been helping users become experts in our technologies since 2020. Prior to joining NanoTemper, Vincenzo earned his Ph.D. in Science of Drug at the University of Salerno, where he studied Medicinal Chemistry. In particular, his studies were focused on the development, optimization, and validation of a screening platform using biophysical and biochemical techniques in order to identify new modulators for epigenetic targets.

Federico Riccardi Sirtori

Federico Riccardi Sirtori

NBE-DMPK
 
Merck R.B.M., Ivrea, Italy; an affiliate of Merck KGaA, Darmstadt, Germany


He is a pharmaceutical chemist with strong competence in mass spectrometry with more than 20 years of experience in LC-MS and GC-MS techniques applied to small molecule and biopolymer (DNA, protein, antibodies). He holds a Laurea degree in organic chemistry and a Ph.D. in pharmaceutical chemistry from Milan University. Federico is currently working in Merck KGaA as Head of NBE-DMPK Innovative Bioanalytics. The department is focused on supporting NBE projects including the development and validation of new bioanalytical methods used to support preclinical studies (PK/TK). He was the author of more than 20 scientific publications.

Registration

Please fill in the on-line registration form here and send a copy of the bank transfert by email to the SSPA2024 Secretariat at secretariat@sspaweb.com. Your registration will be confirmed only upon reception of the Proof of Payment.

Participants to the SSPA2024 can choose between three registration packages: an All Inclusive Registration (attendance in presence), a Basic Registration (attendance in presence) and a Virtual ticket (virtual meeting).

ALL INCLUSIVE

  • Conference Tickets
  • Coffee breaks and meals
  • Abstract book
  • Social dinner
  • 3 nights accommodation§

€ 440

SCI/EFMC members
Before June 23 (*Prices inclusive VAT)
€ 470 After June 23 (*Prices inclusive VAT, last acceptance: September 2, 2024)

€ 470

Not SCI/EFMC members
Before June 23 (*Prices inclusive VAT)
€ 510 After June 23 (*Prices inclusive VAT, last acceptance: September 2, 2024)
§in a double/twin room at a three-star hotel located at a walking distance from the SSPA2024 venue (Single room supplement for 3 nights € 90, Extra night single room € 78, Extra night double room/person € 48)

BASIC

  • Conference Tickets
  • Coffee breaks and meals
  • Abstract book
  • Social dinner
  •  

€ 315

SCI/EFMC members
Before June 23 (*Prices inclusive VAT)
€ 365 After June 23 (*Prices inclusive VAT, last acceptance: September 2, 2024)

€ 350

Not SCI/EFMC members
Before June 23 (*Prices inclusive VAT)
€ 390 After June 23 (*Prices inclusive VAT, last acceptance: September 2, 2024)

VIRTUAL TICKET

  • Conference Tickets
  • Three-day access to lectures
  • Abstract book
  •  
     

€ 125

SCI/EFMC members
Before June 23 (*Prices inclusive VAT)
€ 150 After June 23 (*Prices inclusive VAT, last acceptance: September 10th, 2024)

€ 150

Not SCI/EFMC members
Before June 23 (*Prices inclusive VAT)
€ 170 After June 23 (*Prices inclusive VAT, last acceptance: September 10th, 2024)

Registration policy and fees All registrations will be accepted until September 2, 2024. After this date, only basic and virtual will be accepted. Registration will close on September 10th, 2024.

GDPR The personal information we receive from participants will also be required after the School for statistical purposes and for the dispatch of information on relevant symposia/school in the future. If you do not wish your personal data to be published or distributed, please inform us when you register for the summer school.

Confirmation An e-mail confirming your registration will be sent to you upon reception of a pdf proof of bank trasnfer.

Cancellation must be submitted in writing to the SSPA 2022 Secretariat (secretariat@sspaweb.com). The policy regarding refund of the registration fee is as follows: For all inclusive registrations, cancellations received before August 29th, 2024 will not be charged by any fee but bank fee will be deducted. After August 29th, 2024 no refund will be made. For basic and virtual registrations, for cancellations received before September 10th, 2024 there will not be a cancellation charge (bank fee shall be deducted). After September 10th, 2024 no refund will be made.

Payment All payments should be made in Euro by bank transfer to:
Account holder: Società Chimica Italiana-SSPA
Bank address: DEUTSCHE BANK MILANO C 463, VIALE GIUSTINIANO 1
Iban Code: IT50N0310401603000000821734
Swift Code: DEUT IT M1463
Remittance have to be free of any bank charges to the organizers.

For extra-EU partecipants having troubles with payment by bank transfer a payment by credit card can be arranged upon request. To have it arranged please contact the SSPA2024 secretariat at secretariat@sspaweb.com

Proof of Payment must be submitted by e-mail (secretariat@sspaweb.com) at the time of registration. Please ensure that the name and company/University of each delegate is printed clearly to ensure that the payment will be correctly registered. The payment receipt and the attendance certificate will be sent to the participant by email at the completion of the School.

Insurance The Organizing Committee cannot accept any liability. Participants should make their own arrangements with respect to health and travel insurance.

Fellowships

The Divisione di Chimica Farmaceutica of the Società Chimica Italiana (Italian Chemical Society) grants 3 fellowships for the participation to SSPA2024. Fellowships, covering the registration fee and accommodation (twin room), are reserved to young members of the Divisione di Chimica Farmaceutica with no permanent position at their institution (PhD students, graduated fellows and post-doctoral fellows, RTDa, volunteers or young researchers from other public research bodies), born after 30 April 1989.

Applicants are invited to fill in the on line format and submit a brief description of their research project (max 1 page in A4 format including project title, font size 11 pt, max 4000 characters including spaces) and a supporting letter by the applicant’s mentor stating the candidate position, within 30th April 2024.
For further details click here (in Italian).

To submit your application please fill this form.

Abstract submission

Italian and foreign Ph.D. students in the end phase of their Ph.D. project are kindly invited to orally present their work (20 minutes including discussion). Abstracts will be evaluated by the scientific committee prior acceptance. In the case the number of candidate presentations exceeds the number that can be accommodated in the program, a selection will be made on the basis of novelty, pertinence, and clarity. Abstracts for Ph.D. oral presentations must be submitted before June 16 2024, 12 pm, according to the template given here.

The PhD students whose abstract has been accepted must complete their registration within the early registration date to have their presentation confirmed.

  • The abstract must be written in English and sent as e-mail attachment (word file) to secretariat@sspaweb.com
  • Maximum length is 5 pages
  • Please edit carefully your abstract before submitting it and pay attention to reference style
  • A letter from the PhD mentor stating the PhD status of the presenter and compliance with the requirment of being an experienced PhD student (from the 3rd year onwards) should be submitted together with the abstract
  • We remind you that the presenting author must register before abstract submission

 
Committees

Scientific committee

  • Manuela Bartolini, Chair, Alma Mater Studiorum University of Bologna, IT
  • Giancarlo Aldini, Università degli Studi di Milano, IT
  • Massimo Breda, Aptuit (Verona) S.r.l, an Evotec Company, IT
  • Francesco Epifano, "G. d'Annunzio" University of Chieti-Pescara, IT
  • Alberto Massarotti, Università del Piemonte Orientale, IT
  • Federica Pellati, University of Modena and Reggio Emilia, IT
  • Edoardo Maria Sommella, University of Salerno, IT
  • Caterina Temporini, University of Pavia, IT
  •  

Local Organizing committee

  • Manuela Bartolini, Alma Mater Studiorum University of Bologna, IT
  • Lara Davani, Alma Mater Studiorum University of Bologna, IT
  • Serena Montanari, Alma Mater Studiorum University of Bologna, IT
  • Marina Naldi, Secretariat, Alma Mater Studiorum University of Bologna, IT
  •  
UNIBO QuVi
UNIBO FABIT
DCF
European Federation for Medicinal Chemistry and Chemical Biology

Previous editions

Drug development: bioanalytical aspects

Sept 21-23, 2022 (Rimini, IT)

Summer Course on Pharmaceutical Analysis

Sept 26-27, 2007 (Island of Elba, IT)

Summer Course on Pharmaceutical Analysis

June 29-30, 2006 (Cogne, IT)

Summer Course on Pharmaceutical Analysis

Sept 29-30, 2005 (Rimini, IT)

Summer Course on Pharmaceutical Analysis

May 2, 2004 (Florence, IT)

Summer Course on Pharmaceutical Analysis

July 1-3, 2003 (Cogne, IT)

Summer Course on Pharmaceutical Analysis

June 10-13, 2002 (Island of Elba, IT)

Summer Course on Pharmaceutical Analysis

June 3-5, 2001 (Lipari, IT)

Summer Course on Pharmaceutical Analysis

Sept 30-Oct 3, 2000 (Island of Elba, IT)

Summer Course on Pharmaceutical Analysis

June 28-29, 1999 (Rome, IT)

Summer Course on Pharmaceutical Analysis

June 10-12, 1998 (Island of Elba, IT)

Summer Course on Pharmaceutical Analysis

Sept 15-16, 1997 (Island of Elba, IT)

Summer Course on Pharmaceutical Analysis

June 12-14, 1996 (Island of Elba, IT)